Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726]
Takahito Hara(Takeda (Japan)), Junpei Soeda(Takeda (Japan)), Hiroshi Tanaka(Niigata Cancer Center Hospital), Megumi Morimoto(Takeda (Japan)), T. Miyazaki(Takeda (Japan)), Katsuhiko Nakai(Takeda (Japan)), Akiko Kimura(The University of Osaka)
Cited by 0
Related Papers
Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
|PubMed|2003|427
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
|Journal of Biological Chemistry|2004|212
Inhibition of Extracellular Signal-regulated Protein Kinase or c-Jun N-terminal Protein Kinase Cascade, Differentially Activated by Cisplatin, Sensitizes Human Ovarian Cancer Cell Line
|Journal of Biological Chemistry|1999|174
Inhibition of Phosphorylation of BAD and Raf-1 by Akt Sensitizes Human Ovarian Cancer Cells to Paclitaxel
|Journal of Biological Chemistry|2002|172